Home › Allergan, Inc. › Natrelle 133 Plus Tissue Expanders

Natrelle 133 Plus Tissue Expanders

Allergan, Inc. · Model 133P-FV-14 · UDI-DI 10888628009707

LCJ Prescription

510(k) clearances

5,147

Adverse events (4 deaths)

Recalls

Facilities

Description

133P-FV-14

Recalls

Date	Firm	Reason
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-18	Mentor Texas, LP.	Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break.
2026-02-02	B Braun Medical Inc	The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.
2026-02-02	B Braun Medical Inc	The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.
2026-02-02	B Braun Medical Inc	The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.